PPARG and non-small cell lung carcinoma: Chang et al. [146] have shown that agonists (thiazolidinediones and 15d-PGJ2) of the steroid peroxisome proliferator-activated receptor gamma (PPARγ) promote differentiation of the NSCLC cells, and at higher concentration cause arrest of cell growth and induction of apoptosis.